IDERA PHARMACEUTICALS, INC.·4

Sep 20, 5:06 PM ET

PIEN HOWARD H 4

4 · IDERA PHARMACEUTICALS, INC. · Filed Sep 20, 2018

Insider Transaction Report

Form 4
Period: 2018-09-18
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-09-18+23,00023,000 total
    Exercise: $7.99Exp: 2028-09-18Common Stock (23,000 underlying)
Footnotes (1)
  • [F1]The option was granted under the Issuer's 2013 Stock Incentive Plan. The option vests and becomes exercisable over a three-year period commencing on September 18, 2018. Thirty-three percent (33%) of the underlying shares vest and become exercisable on September 18, 2019 (first anniversary of the date of grant) with the balance of the underlying shares vesting in eight equal quarterly installments over the remaining two years of the three-year period, subject to continued service with the Issuer. The option automatically becomes exercisable in full upon the occurrence of a change in control of the Issuer.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -